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Objective: To determine the feasibility of transcaval transjugular intrahepatic
portosystemic shunt (TIPS) creation in patients with unusual anatomy between
the hepatic veins and portal bifurcation, and inaccessible or inadequate hepatic
veins.
Materials and Methods: Transcaval TIPS, performed in six patients, was indi-
cated by active variceal bleeding (n=2), recurrent variceal bleeding (n=2),
intractable ascites (n=1), and as a bridge to liver transplantation (n=1). The main
reasons for transcaval rather than classic TIPS were the presence of an unusual-
ly acute angle between the hepatic veins and the level of the portal bifurcation
(n=3), hepatic venous occlusion (n=2), and inadequate small hepatic veins (n=1).
Results: Technical and functional success was achieved in all patients. The
entry site into liver parenchyma from the inferior vena cava was within 2 cm of the
atriocaval junction. Procedure-related complications included the death of one
patient due to hemoperitoneum despite the absence of contrast media spillage at
tractography, and another suffered reversible hepatic encephalopathy.
Conclusion: In patients with unusual anatomy between the hepatic veins and
portal bifurcation, and inaccessible or inadequate hepatic veins, transcaval TIPS
creation is feasible.
ransjugular intrahepatic portosystemic shunt (TIPS) has been successfully
used to manage uncontrolled variceal bleeding, intractable abdominal as-
cites, hepatic hydrothorax, and Budd-Chiari syndrome (1 6). Classically,
the shunt tract is created between the hepatic and portal vein, but when the hepatic
veins are inaccessible or inadequate because of occlusion, as in Budd-Chiari syndrome
or tumor, and when the portal vein cannot be punctured because of the cephalad loca-
tion of its bifurcation relative to the hepatic veins, the transcaval route is inevitable.
Previously reported cases of transcaval TIPS involved localization of the right portal
vein followed by the percutaneous portal vein approach (7 9), though one recent
study (10) reported blind puncture of the portal vein from the IVC in five cases. In this
study, transcaval TIPS were created in the classic manner, using only the right internal
jugular vein approach and blind transcaval puncture of the right portal vein, without
additional percutaneous localization of the right portal vein. The purpose of this study
was to evaluate the feasibility of transcaval TIPS creation in patients with unusual
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Between May 1999 and April 2001, transcaval TIPS was
performed in six patients (four men and two women; age
range, 30 73 years). The clinical data are listed in Table 1.
Indications for TIPS were active variceal bleeding (n=2),
recurrent variceal bleeding (n=2), intractable ascites (n=1),
and as a bridge to liver transplantation (n=1). All patients
had liver cirrhosis, and three had hepatocellular carcinoma
with underlying viral liver cirrhosis. In two, Budd-Chiari
syndrome was associated; this was subsequent to Behcet’s
disease in one patient and idiopathic in the other. The main
reasons for transcaval rather than classic TIPS were the
presence of an unusually acute angle between the hepatic
veins and the level of the portal bifurcation (n=3), hepatic
venous occlusion (n=2), and inadequate small hepatic veins
(n=1). The Institutional Review Board approved the proce-
dure, and informed consent was obtained from each pa-
tient or their legal guardian.
In two patients with hepatic venous occlusion and one
with inadequate small hepatic veins, transcaval TIPS was
first attempted, and in three with patent and adequate he-
patic veins, the treatment of first choice was classical TIPS.
After these techniques failed due to the unusually acute
angle between the hepatic veins and the level of the portal
bifurcation, venacavography of the inferior vena cava
(IVC) was performed to confirm the presence of its retro-
hepatic segment, and direct cavoportal puncture was at-
tempted. A 16-gauge Colapinto needle and a 9-F Teflon
sheath (Transjugular Liver Access Set; Cook, Bloomington,
Ind., U.S.A.) were coaxially loaded over a guide-wire
through the right internal jugular vein. Percutaneously
placed anatomic landmarks were not used. After CT scan-
ning, the relationship between the retrohepatic segment of
the IVC and the portal vein was reconstructed in the oper-
ator’s mind, and the ventral IVC wall was punctured and
the needle directed toward the portal vein. If necessary,
the Colapinto needle curve was made more acute to
achieve the required posterior-to-anterior trajectory
through the liver. After portal vein puncture, a 0.035-inch
hydrophilic guide-wire (Terumo, Tokyo, Japan) was intro-
duced through the needle and placed in the splenic or su-
perior mesenteric vein, and direct portography was per-
formed using a 5-F angiographic catheter. After measuring
the pressure in the main portal vein, the needle tract was
dilated with an 8- or 10-mm balloon catheter (Medi-
Tech/Boston Scientific, Watertown, Mass., U.S.A.). A 9-F
sheath was placed in the tract, and direct tractography was
performed to visualize the extravasation of contrast medi-
um and biliary communication. After verifying that these
were absent, a self-expandable Wallstent (10 mm in diame-
ter / 7 or 9 cm in length) was deployed. Post-stenting bal-
loon dilation with an 8- or 10-mm balloon was performed
to achieve a portosystemic pressure gradient of less than
15 mmHg, as measured from the main portal vein to the
right atrium.
The TIPS tract was evaluated by color and spectral
Doppler ultrasonography. The first control study was per-
formed 1 5 days after the initial procedure, and subse-
quent examination was followed by control studies at
three-month intervals. Indirect portography was available
in patients with hepatocellular carcinoma.
RESULTS
The results of transcaval TIPS creation are listed in Table
1. Technical and functional success was achieved in all pa-
tients (Figs. 1 3).
The entry site into liver parenchyma from the IVC was
within 2 cm of the atriocaval junction. The puncture site in-
volved was the right portal vein in four patients, the left
portal vein in one, and the bifurcation level of the right
and left portal vein in one. Before TIPS creation, the mean
pressure gradient between the main portal vein and right
atrium was 33 mmHg, and TIPS creation caused this to de-
Lee et al.
36 Korean J Radiol 4(1), March 2003
Table 1. Clinical Data and Results of Transcaval Transjugular Intrahepatic Portosystemic Shunt
Case Sex/Age Underlying Disease Reason for Transcaval TIPS PrePG PostPG Complication Primary Patency
1 M/30 LC, HCC, BD, BCS Occlusion of hepatic veins 28 15 10 months
2 M/41 LC Acute angle between HV and PV 34 13 E >16 months
3 M/54 LC, HCC Acute angle between HV and PV 40 12 Death N/A
4   F/38 LC, BCS Occlusion of hepatic veins 37 10 N/A
5 F/53 LC  Acute angle between HV and PV 27 11 >16 months
6 M/73 LC, HCC Inadequate small hepatic veins 30 09 12 months
Note. TIPS=transjugular intrahepatic portosystemic shunt, PrePG=pre-TIPS pressure gradient (mmHg), PostPG=post-TIPS pressure gradient (mmHg),
LC=liver cirrhosis, HCC=hepatocellular carcinoma, BD=Behcet’s disease, BCS=Budd-Chiari syndrome, HV=hepatic vein, PV=portal vein, E=ence-
phalopathy, N/A=not applicable,  the patient expired one day after the procedure, and thus the patency rate could not be estimated,   the patient underwent
liver transplantation one month after the procedure, and the patency rate could not, therefore, be estimated.crease significantly, to 12 mmHg. In addition, post-TIPS di-
rect portography demonstrated rapid flow into the shunt
tract.
Procedure-related complications included the death of
one patient due to hemoperitoneum despite the absence of
contrast media spillage at tractography, and another suf-
fered reversible hepatic encephalopathy.
Because this first patient, who had intractable ascites,
died one day after the procedure (case 3), and another un-
derwent liver transplantation one month after the proce-
dure (case 4), the results of follow-up were available in on-
ly four of the six patients. The symptoms of variceal bleed-
ing were well controlled. Two of the four patients (cases 2
and 5) who were followed up showed primary patency for
more than sixteen months. TIPS was revised in two pa-
tients (cases 1 and 6), and in both, gastric fundal variceal
bleeding recurred. Direct portography performed via the
right internal jugular vein approach demonstrated malfunc-
tion of the stent due to diffuse intimal hyperplasia. In case
1, the TIPS tract was dilated with a 10-mm balloon, and
the portosystemic pressure gradient decreased from 25 to
10 mmHg. Despite this drop to an effective range, a
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Fig. 1. Case 2. A 41-year-old man with active variceal bleeding. A, B. Sequential MR
images (1 cm slice thickness) depict approximation of the right proximal hepatic vein
(arrow in A) and right portal vein (arrow in B).
C. After classic puncture at the proximal hepatic vein, only the peripheral portal
branch was punctured. Approximation of the estimated proximal right hepatic vein and
right portal vein is noted (arrows).
D. Following transcaval TIPS creation using a Wallstent 10 mm in dianeter and 7 cm
in length, the portosystemic gradient decreased from 34 mmHg to 13 mmHg.
Subsequent direct portography demonstrated good flow through the stent and de-
creased flow into the coronary varix.
C
Dmarkedly dilated gastric fundal varix persisted, and further
variceal embolization was performed by injecting his-
toacryl. In case 6, dilatation with a 10-mm balloon alone
did not lower the portosystemic pressure gradient to the
effective range, so a 10-mm/9-cm Wallstent was again de-
ployed, followed by post-stenting dilatation with a 10-mm
balloon. The portosystemic pressure gradient then de-
creased from 25 to 8 mmHg, and variceal filling was not
demonstrated. Secondary patency was well maintained
during the follow-up period.
DISCUSSION
Transcaval TIPS has been documented in various reports
of different conditions. It was performed, for example, in a
patient with acute Budd-Chiari syndrome and a throm-
bosed surgical mesocaval shunt and stenosis of the IVC (7).
Another case involved a patient who lacked the hepatic
veins capable of supporting TIPS (8), and other reports
have described a case in which transfemoral transcaval
TIPS was performed to relieve occlusion of both internal
jugular veins (9), and unsuccessful revision of previously
performed TIPS (10).
If a transcaval shunt is to be safe, it must exit the IVC at
a site that is well invested by the fibrous tissue of the
retroperitoneum. If the shunt exits a caudal, intraperitoneal
portion of the IVC, then bleeding through the porous stent
mesh at this site might occur. The retrohepatic IVC, or safe
zone, has been measured in two cadaver studies. Chang et
al. (11) reported that in 60 livers taken from adult cadavers
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Fig. 2. Case 4. A 38-year-old woman who was a candidate for liver
transplantation.
A. Contrast-enhanced CT scan shows a thrombosed hepatic vein
(arrow), inhomogeneous parenchymal enhancement, and a sub-
stantial amount of ascites, compatible with Budd-Chiari syndrome.
B, C. IVC venogram (B) and angiogram (C) obtained after direct in-
trahepatic puncture show the collateralization typical of Budd-Chiari
syndrome.
D. Transcaval TIPS was performed due to occlusion of hepatic
veins.
A
BC Dand free from gross pathologic change, the average length
of the retrohepatic segment was 7.1 cm, while Camargo et
al. (12) found that in 30 pathologically sound livers from a
similar source, the average length of this segment was 6.7
(range, 3.5 10.9) cm. Saxon and Keller (13) stated that
the hepatic vein usually enters the IVC within 2 cm of the
right atrium, and that a point not more than 6 cm from this
was therefore the safest puncture point within the ventral
wall of the IVC. They also argued that since the caval exit
site is posterior to the standard exit site through the hepat-
ic vein, excursion of the curved puncture needle should be
more ventral.
Because the length of the retrohepatic segment of the
IVC may vary in patients with cirrhosis, two important
points should be borne in mind when performing transcav-
al TIPS. First, the puncture site should be adjacent to the
native orifice of the hepatic veins. The advantages of this
are that puncture of the retrohepatic segment of the IVC is
thus guaranteed, and during puncture, the Colapinto nee-
dle will not be pushed back. Second, it is crucial to ensure
that no leakage occurs at either the caval entry site or the
tract, and that there is no communication between the bil-
iary tree and the tract. Digital subtraction angiography af-
ter the injection of contrast medium through a sidestream
adaptor and with a guide-wire appropriately positioned is
able to demonstrate the presence or absence of contrast
medium leakage into the extrahepatic space and communi-
cation between the biliary tree and the tract.
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Fig. 3. Case 6. A 73-year-old man with active variceal bleeding.
A. CT scan shows occlusion of the right portal vein due to repeated transcatheter ar-
terial chemoembolization and gastric fundal varices.
B, C. Because the middle (B) and left (C) hepatic veins were too small, classic TIPS
was not possible.
D. Transcaval TIPS was performed via the left portal vein.
C
DWhere there is biliary communication, bile leakage into
the shunt tract can induce thrombosis and pseudointimal
hyperplasia, and the use of a stent-graft to prevent early
tract occlusion is recommended. In addition, where there is
extravasation of contrast medium, the location and amount
of this, and whether it is contained extravasation or free
spillage, should first be evaluated. Possible therapeutic op-
tions, including occlusion, bare stent insertion, and stent-
graft insertion, should then be considered. Seong et al. (10)
reported that in three of five cases in which transcaval
TIPS involved the extravasation of contrast medium, this
was confined to hepatic subcapsular space or the pericaval
and subdiaphragmatic area. They stated that after tract di-
latation and bare stent placement in these patients, there
was no evidence of bleeding while their condition was sta-
ble, and the reason this did not occur was that the shunt
tract exited the retrohepatic segment of the IVC at a site
well invested by retroperitoneal fibrous. However, if con-
trast medium is extravasated as a result of free spillage,
particularly through leakage from the extrahepatic portion
of the portal vein, treatment options include 1) portal vein
tamponade with an occlusion balloon, and rapid shunt for-
mation through a different tract; 2) placement of a stent
graft; or 3) completion of the intra-tract procedure by
placement of a conventional bare mesh stent (14 16). A
few recent reports have stated that stent-graft deployment
in a TIPS tract can increase the primary patency period,
and that the use of a stent-graft of appropriate size may
therefore be a feasible therapeutic option (17, 18).
In patients with a large amount of ascites and small liver
volume, the risk of hemoperitoneum during repeated
puncture is high, due to laceration of the inferior liver cap-
sule. An example of this is case 3: although contrast medi-
um had not leaked into the extrahepatic space, the patient
died due to hemoperitoneum, an outcome which may be
due to laceration of the inferior liver capsule due to repeat-
ed puncture.
One of the suggested advantages of transcaval TIPS is
that in theory, transcaval shunts may provide longer paten-
cy because the hepatic vein is entirely avoided. However,
until a large series is reported, the superiority of the proce-
dure in this respect remains unproven.
It has been reported that transcaval TIPS in patients
awaiting orthotopic liver transplant offers a further benefit
by positioning the outflow (caval) end of the stent in the
intrahepatic IVC segment (9, 19, 20). This can avoid both
supra- and infrahepatic caval cuffs and can subsequently
decrease any theoretical risk of interference with inferior
vena cava segments crucial for orthotopic liver transplant
(9).
Although the number of patients in this study was limit-
ed, the favorable results indicate that transcaval TIPS cre-
ation is feasible in patients with unusual anatomy between
the hepatic veins and the portal bifurcation, and inaccessi-
ble or inadequate hepatic veins.
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